News

Home / News

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,regarding acquisition of right-of-use asset from a re

2024.4.1

1.Name and nature of the underlying asset (e.g., land located at Sublot XX, Lot XX, North District, Taichung City):
Taichung office, 4F.-1, No. 424, Zhongming Rd., Taichung City, Taiwan (R.O.C.)

2.Date of the occurrence of the event:2024/04/01

3.Transaction unit amount (e.g.XX square meters, equivalent to XX ping), unit price, and total transaction price: Transaction amount: Taichung office︰
Transaction unit amount:11 pings
Unit price:NT$450 per ping per month
Total monthly cost: NT$8,300 per month (including water, electricity,and management fees)
Total right-of-use asset value: NT$171,076

4.Trading counterparty and its relationship to the Company (if the trading counterparty is a natural person and furthermore is not a related party of the Company, the name of the trading counterparty is not required to be disclosed):
(1)Trading counterparty:TSH Biopharm Corporation Limited
(2)relationship to the Company:Parent Company of the Company

5.Where the trading counterparty is a related party, announcement shall also be made of the reason for choosing the related party as trading counterparty and the identity of the previous owner, its relationship with the Company and the trading counterparty, and the previous date and monetary value of transfer:
(1)reason for choosing the related party as trading counterparty:Based on overall operational planning and management needs
(2)The identity of the previous owner, its relationship with the Company andthe trading counterparty, and the previous date and monetary value of transfer:NA

6.Where an owner of the underlying assets within the past five years has been a related party of the Company, the announcement shall also include the date and price of acquisition and disposal by the related party, and its relationship to the Company at the time of the transaction:NA

7.Projected gain (or loss) through disposal (not applicable for acquisition of assets; those with deferral should provide a table explaining recognition):NA

8.Terms of delivery or payment (including payment period and monetary value), restrictive covenants in the contract, and other important terms and conditions:
(1)Payment terms: The lease period is from Apr.1, 2024, to Dec.31, 2025. The monthly rent is NT$8,300 (including water, electricity, and management fees, excluding VAT).
(2)Restrictive covenants and other important terms and conditions
2.1For the exclusive use of CYB for business operations
2.1Without the consent of TSH, CYB may not sublease, re-lease, transfer, sublet, or allow third parties to use the leased property through other means such as cooperative operation. Otherwise, TSH has the right to immediately terminate the lease, forfeit the deposit, and reclaim the leased property.

9.The manner of deciding on this transaction (such as invitation to tender, price comparison, or price negotiation), the reference basis for the decision on price, and the decision-making department:
(1)The manner of deciding on this transaction, the reference basis for the decision on price:Taking into account the surrounding market conditions and the negotiation results of both parties
(2)the decision-making department:Chief Operations Officer

10.Name of the professional appraisal firm or company and its appraisal price:NA

11.Name of the professional appraiser:NA

12.Practice certificate number of the professional appraiser:NA

13.The appraisal report has a limited price, specific price, or special price:NA

14.An appraisal report has not yet been obtained:NA

15.Reason for an appraisal report not being obtained:NA

16.Reason for any significant discrepancy with the appraisal
reports and opinion of the CPA:NA

17.Name of the CPA firm:NA

18.Name of the CPA:NA

19.Practice certificate number of the CPA:NA

20.Broker and broker's fee:NA

21.Concrete purpose or use of the acquisition or disposal: As an office space usage

22.Any dissenting opinions of directors to the present transaction:NA

23.Whether the counterparty of the current transaction is a related party:YES

24.Date of the board of directors’ resolution:NA

25.Date of ratification by supervisors or approval by the audit committee:NA

26.The transaction is to acquire a real property or right-of-use asset from a related party:YES

27.The price assessed in accordance with the Article 16 of the Regulations Governing the Acquisition and bDisposal of Assets by Public Companies:NA

28.Where the above assessed price is lower than the transaction price, the price assessed in accordance with the Article 17 of the same regulations:NA

29.Any other matters that need to be specified:NA